Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001857294 | SCV002144830 | pathogenic | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 441133). This variant is also known as p.P14fs. This premature translational stop signal has been observed in individual(s) with familial exudative vitreoretinopathy (PMID: 27668459, 30452590). This variant is present in population databases (no rsID available, gnomAD 0.001%). This sequence change creates a premature translational stop signal (p.Pro14Serfs*44) in the FZD4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FZD4 are known to be pathogenic (PMID: 25711638, 26244290). |
Gene |
RCV001857294 | SCV005078681 | pathogenic | not provided | 2023-12-10 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as c.39-49delCCCGGGGGC and P14fsX5; This variant is associated with the following publications: (PMID: 32884843, 34860240, 27668459, 30452590, 35876299, 20938005) |
Genome |
RCV000509233 | SCV000607297 | not provided | Familial exudative vitreoretinopathy | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |